Saturday, May 18, 2024
HomeMedicineInternal MedicineStudy takes first steps to test new way to screen signs of...

Study takes first steps to test new way to screen signs of blocked arteries

As discussed in a recent study, researchers are taking the initial steps towards developing a test to screen for reduced blood flow to the heart.

 

Acute coronary syndrome (ACS) is an umbrella term for symptoms arising from reduced or blocked blood supply to the heart. The most common conditions under ACS are heart attacks and angina. The medical term that describes reduced blood flow to the heart is myocardial ischemia and it was the focus of a pilot study carried out at Duke University, USA.

The study published in PLOS ONE is a proof-of-concept study that aims to demonstrate the feasibility of using specific metabolites that show distinct changes in their levels in individuals suffering from myocardial ischemia or blocked arteries that is induced by a stress-test.

The heart is metabolically active

The heart is a metabolically active organ. Metabolite factors can act as biomarkers that aid in risk assessment. A number of studies have shown that metabolomics profiling can help to identify early signs of blocked arteries, or of injury that may result in lowered blood supply to the heart. Medium and long-chain acylcarnitines are examples of metabolites that have been found to be associated with long-term risk for heart attacks.

For this study, patients in the emergency department reporting symptoms of coronary disease were considered as study subjects. Additionally, blood tests and ECG were carried out to exclude patients suffering from a heart attack or other conditions that would preclude them from participating in the stress tests. Blood samples were collected from participants prior to the stress test and two hours post-stress test.

Acylcarnitines: compounds needed to break down fatty acids

They analyzed samples for acylcarnitines and amino acids as prior work had demonstrated that these metabolites could act as predictive biomarkers for ACS. Acylcarnitines are compounds needed for the breakdown of fatty acids, which is a major source of energy. A buildup of acylcarnitines due to incomplete fatty acid oxidation has been associated with a number of metabolic disorders such as type 2 diabetes, obesity, and cardiovascular disease.

Metabolomic profiling may have enough power to determine risk in patients

The current study identified five metabolites that included medium and long-chain acylcarnitines that show changes in their levels in patients with myocardial ischemia as compared to normal individuals after stress tests.  These results provide a sound basis for further work and are in alignment with other studies that show that metabolomic profiling has enough discriminatory power to be used in risk stratification of outpatients.

As described by Dr. Limkakeng, lead author of the study, in a press release, “Augmenting the imaging of a stress test with metabolite biomarkers could make that [screening for invasive procedures like catheterization] more accurate or more efficient.”

This study included only 40 patients. Hence, additional studies with a larger number of subjects are essential to ascertain if the results are true for a larger population and can be developed into a screening tool in the emergency departments.

Written by Bhavana Achary, Ph.D.

References:

  1. Limkakeng AT Jr, Henao R, Voora D, O’Connell T, Griffin M, Tsalik EL, Shah S, Woods CW, Ginsburg GS. Pilot study of myocardial ischemia-induced metabolomics changes in emergency department patients undergoing stress testing. PLoS One. 2019 Feb 1;14(2)
  2. Press release retrieved from https://www.eurekalert.org/pub_releases/2019-02/dumc-btf013019.php
Bhavana Achary PhD
Bhavana Achary PhD
Bhavana Achary completed her Ph.D in Molecular Biology and Biochemistry at the Pennsylvania State Universisty, USA, studying gene regulation. Pivoting from the bench to the writer's desk, Bhavana hopes to bring the advances in science and health research to a broader audience while maintaining the scientific rigour and knowledge gained over her years in research. She enjoys the opportunity to keep abreast of the latest in medical research while also making it more accessible to a lay audience. Currently based in Singapore, Bhavana enjoys exploring the Southeast Asian region.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

Recognizing HIE: A Call for Advocacy

Have you heard of HIE? It’s the second leading cause of infant mortality and lifelong disability worldwide. 2-3 per 1,000 live births in high-income...

Joke Of The Day – May 18

The man told his doctor that he wasn’t able to do all the things around the house that he used to do. When the examination...

ADVERTISE WITH US

error: Content is read-only and copy-protected.